Abstract:Disease-specific autoantibodies are considered the most important biomarkers for systemic sclerosis (SSc), due to their ability to stratify patients with different severity and prognosis. Anti-nuclear antibodies (ANA), occurring in subjects with isolated Raynuad's phenomenon, are considered the strongest independent predictors of definite SSc and digital microvascular damage, as observed by nailfold videocapillaroscopy. ANA are present in more than 90% of SSc, but ANA negativity does not exclude SSc diagnosis: a little rate of SSc ANA negative exists and shows a distinct subtype of disease, with less vasculopathy, but more frequent lower gastrointestinal involvement and severe disease course. Anti-centromere, anti-Th/To, and anti-Topoisomerase I antibodies could be considered as classical biomarkers, covering about 60% of SSc and defining patients with well-described cardio-pulmonary complications. In particular, anti-Topoisomerase I represent a risk factor for development of diffuse cutaneous involvement and digital ulcers in the first 3 years of disease, as well as severe interstitial lung disease (ILD). Anti-RNA polymerase III is a biomarker with new clinical implications: very rapid skin thickness progression, gastric antral vascular ectasia, the occurrence of synchronous cancers, and possible association with silicone breast implants rupture. Moreover, novel SSc specific autoantibodies have been globally described in about 10% of "seronegative" SSc patients: anti-elF2B, anti-RuvBL1/2 complex, anti-U11/U12 RNP, and anti-BICD2 depict specific SSc subtypes with severe organ complications. Many autoantibodies could be considered markers of overlap syndromes, including SSc. Anti-Ku are found in 2-7% of SSc, strictly defining the PM/SSc overlap. They are associated with synovitis, joint contractures, myositis, and negatively associated with vascular manifestation of disease. Anti-U3RNP are associated with a well-defined clinical phenotype: Afro-Caribbean male patients, younger at diagnosis, and higher risk of pulmonary hypertension and gastrointestinal involvement. Anti-PM/Scl define SSc patients with high frequency of ILD, calcinosis, dermatomyositis skin changes, and severe myositis. The accurate detection of autoantibodies SSc specific and associated with overlap syndromes is crucial for patients' stratification. ANA should be correctly identified using indirect immunofluorescent assay and a standardized way of patterns' interpretation. The gold-standard technique for autoantibodies' identification in SSc is still considered immunoprecipitation, for its high sensitivity and specificity, but other assays have been widely used in routine practice. The identification of SSc autoantibodies with high diagnostic specificity and high predictive value is mandatory for early diagnosis, a specific follow-up and the possible definition of the best therapy for every SSc subsets. In addition, the validation of novel autoantibodies is mandatory in wider cohorts in order to restrict the gap of so-called seronegative SSc patients.

Rare diseases that mimic Systemic Lupus Erythematosus (Lupus mimickers)

Leprosy with Ana Positive Mistaken for Connective Tissue Disease

A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum

Chronic Liver Disease: A Mimic of Systemic Lupus Erythematosus

Is Molecular Mimicry the Missing Link between Those Two Factors?

A Comprehensive Review of Immune-Mediated Dermatopathology in Systemic Lupus Erythematosus.

[Rare Autoimmune Diseases Role of Genetics - Example of Systemic Lupus Erythematosus]

The Multiple Faces of Systemic Lupus Erythematosus: Pearls and Pitfalls for Diagnosis

IL-10 and IFN-γ As Markers for Early Recognition of Pediatric Systemic Lupus Erythematosus Complicated with Macrophage Activation Syndrome.

Possible novel biomarkers of organ involvement in systemic lupus erythematosus

Oral Secondary Syphilis Mimicking Oral Manifestations Of Systemic Erythematosus Lupus.

Case report of a 28 years old woman with lepromatous leprosy mimicking systemic lupus erythematosus

S4669 The Great Imitator: Syphilis Mimicking Autoimmune Liver Disease

Chronic myelomonocytic leukemia mimicking hematologic systemic lupus erythematosus

Serological analysis of autoantibody mimicking anti-Rh(e) specificity: a case report

Optimal Selection of IFN-α-Inducible Genes to Determine Type I Interferon Signature Improves the Diagnosis of Systemic Lupus Erythematosus

Two Clusters of Systemic Lupus Erythematosus Patients with Muscle Involvement in a Chinese Cohort

Identification of Serum Biomarkers for Systemic Lupus Erythematosus Using a Library of Phage Displayed Random Peptides and Deep Sequencing.

Anaplastic Large Cell Lymphoma Misdiagnosed as Systemic Lupus Erythematosus: A Report of a Rare Case

Mendelian Causes of Autoimmunity: the Lupus Phenotype

Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers